恒瑞医药:HRS-7535片上市申请获受理

财中社
Sep 03

9月3日,恒瑞医药(600276/01276)发布公告,公司HRS-7535片的药品上市许可申请获国家药监局受理。  公告提到,HRS-7535片适用于在控制饮食和增加运动基础上,初始体重指数(BMI)符合相关要求的成人的长期体重管理。  此次申报上市,是基于一项HRS-7535片在成人超重或肥胖患者中开展的多中心、随机、双盲、安慰剂对照、平行设计的关键Ⅲ期临床试验,旨在评估HRS-7535 片...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10